Medical Marketing & Media

• Shake-up at top for J&J, as Weldon exits CEO post
• Samples no longer hold sway in pharma marketing mix: study
• Setback, not disaster, for Gilead hep. C regimen, analysts say
• Industry says Sunshine reporting recs will confuse, not clarify
• Drugmakers look outside labs to offset R&D risk

Read More

PRWeek

• Florida releases AIDS initiative RFP
• Galen replaces Jones as comms leader at Novartis
• Tackling the problem of childhood obesity
• NC Blue Cross relaunches 'scapegoat' campaign
• Komen reversal shows power of social networks

Read More

Fierce Pharma

• Mexico's Genomma lodges $834M bid for Prestige
• Biotech investors collect a fraction of milestone cash
• J&J picks Gorsky over McCoy to fill CEO's seat
• Shire to boost Vpriv, Replagal with EMA-approved plant
• Abbott prevails as Supremes pass on J&J patent suit

Read More

Reuters

• Olympus says India exec likely had no ties to scandal
• Top Olympus lender denies board ambush, but may fill chair
• Exercise in Pregnancy Safe for Baby, Study Finds
• TSX may open lower on weak European, Chinese data
• Chavez surgery unsettles Venezuela ahead of election

Read More

The Pink Sheet

• TREAT Act Wants Accelerated Approval Change, But Uses Existing Language
• Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says
• GPhA’s Neas Preaches Vigilance Against Reopening Hatch-Waxman Act
• FDA’s ANDA Approvals
• GSK Says R&D Productivity Up, But Story Is About Culture, Not Numbers

Read More

New York Times

• Colonoscopy Lowers Rate of Cancer Deaths, Study Finds
• F.D.A. Approves Imports Amid Shortage of 2 Cancer Drugs
• Y Chromosome, Though Diminished, Is Holding Its Ground
• Well: For Baldness, Turning to Leg Hair
• J.& J. Chief to Resign One Role

Read More

Pharma Marketing News

• Big Bad Pharma
• Mobile Regulatory Fears
• Some Unregulated Physician Smartphone Apps May Be Buggy
• The Coming Pharma Digital Depression

Read More

Pharmaceutical Executive

• AstraZeneca's Real-World Bet
• Sales: Fully Mobilize Your Mobile Technology
• The Italian's Job — Guido Rasi's EMA Challenge
• Video: GSK Upbeat in Fourth Quarter Review
• FDA Unveils Guidance for Biosimilar Development

Read More

CNN.com

Read More